MicroRNAs in diabetic cardiomyopathy and clinical perspectives
Authors:
Open Access
- 25 June 2014
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Genetics
- Vol. 5, 185
Abstract
MicroRNAs in diabetic cardiomyopathy and clinical perspectivesKeywords
This publication has 34 references indexed in Scilit:
- Differential Expression of Dicer, miRNAs, and Inflammatory Markers in Diabetic Ins2+/− Akita HeartsCell Biochemistry and Biophysics, 2013
- Predictors and prevention of diabetic cardiomyopathyDiabetes, Metabolic Syndrome and Obesity, 2013
- miR-141 as a regulator of the mitochondrial phosphate carrier (Slc25a3) in the type 1 diabetic heartAmerican Journal of Physiology-Cell Physiology, 2012
- Emerging role of epigenetics and miRNA in diabetic cardiomyopathyCardiovascular Pathology, 2012
- Deregulation of microRNA-503 Contributes to Diabetes Mellitus–Induced Impairment of Endothelial Function and Reparative Angiogenesis After Limb IschemiaCirculation, 2011
- miRNAs as molecular biomarkers of cancerExpert Review of Molecular Diagnostics, 2010
- Transcriptional coactivator p300 regulates glucose-induced gene expression in endothelial cellsAmerican Journal of Physiology-Endocrinology and Metabolism, 2010
- Regulation of cardiomyocyte hypertrophy in diabetes at the transcriptional levelAmerican Journal of Physiology-Endocrinology and Metabolism, 2008
- Impact of New-Onset Diabetes Mellitus on Cardiac Outcomes in the Valsartan Antihypertensive Long-Term Use Evaluation (VALUE) Trial PopulationHypertension, 2007
- MicroRNAsCell, 2004